Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Annals of Oncology

Topics

Medicine

Cancer Oncology

Internal Medicine

Gastroenterology

Pathology And Forensic Medicine

Show all topics

DOI

10.1093/annonc/mdu141

License

publisher-specific-oa